DE68918649T2 - Lebende Newcastle-Krankheit-Virus-Vakzine. - Google Patents

Lebende Newcastle-Krankheit-Virus-Vakzine.

Info

Publication number
DE68918649T2
DE68918649T2 DE68918649T DE68918649T DE68918649T2 DE 68918649 T2 DE68918649 T2 DE 68918649T2 DE 68918649 T DE68918649 T DE 68918649T DE 68918649 T DE68918649 T DE 68918649T DE 68918649 T2 DE68918649 T2 DE 68918649T2
Authority
DE
Germany
Prior art keywords
virus vaccine
newcastle disease
disease virus
live newcastle
live
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE68918649T
Other languages
English (en)
Other versions
DE68918649D1 (de
Inventor
Wiltenburg Nico Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dimminaco AG
Original Assignee
Duphar International Research BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar International Research BV filed Critical Duphar International Research BV
Application granted granted Critical
Publication of DE68918649D1 publication Critical patent/DE68918649D1/de
Publication of DE68918649T2 publication Critical patent/DE68918649T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE68918649T 1988-07-18 1989-07-12 Lebende Newcastle-Krankheit-Virus-Vakzine. Expired - Lifetime DE68918649T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8801819 1988-07-18

Publications (2)

Publication Number Publication Date
DE68918649D1 DE68918649D1 (de) 1994-11-10
DE68918649T2 true DE68918649T2 (de) 1995-03-23

Family

ID=19852645

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68918649T Expired - Lifetime DE68918649T2 (de) 1988-07-18 1989-07-12 Lebende Newcastle-Krankheit-Virus-Vakzine.

Country Status (9)

Country Link
US (1) US5149530A (de)
EP (1) EP0351908B1 (de)
JP (1) JP2655726B2 (de)
AT (1) ATE112490T1 (de)
DE (1) DE68918649T2 (de)
DK (1) DK175318B1 (de)
ES (1) ES2060740T3 (de)
HU (1) HU204439B (de)
IE (1) IE65736B1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250298A (en) * 1988-10-07 1993-10-05 University Of Delaware Live attenuated newcastle disease virus vaccines and preparation thereof
FR2682966B1 (fr) * 1991-10-29 1994-12-02 Rhone Merieux Preparation d'antigenes et de vaccins du virus de la mystery disease, antigenes et vaccins obtenus pour la prevention de cette maladie.
CA2181862C (en) * 1995-08-01 2009-12-22 Carla Christina Schrier Mild newcastle disease virus vaccine
DE69632235T2 (de) * 1995-10-18 2004-08-26 Akzo Nobel N.V. Newcastle-Krankheitsvirus-Kombinationsimpfstoff
EP0848956A1 (de) * 1996-12-17 1998-06-24 Dimminaco Ag/Sa/Ltd. In ovo Impfung gegen die Newcastle-Krankheit
TW200502402A (en) * 2002-12-06 2005-01-16 Wyeth Corp Escape mutants of newcastle disease virus as marker vaccines

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2798835A (en) * 1954-01-18 1957-07-09 American Cyanamid Co Newcastle disease and infectious bronchitis vaccines and production thereof
US3876763A (en) * 1970-12-29 1975-04-08 Shionogi & Co Infectious coryza infectious bronchitis and newcastle disease vaccines and production thereof
US4053583A (en) * 1976-03-01 1977-10-11 Smithkline Corporation Live newcastle disease virus vaccines
BE853923A (fr) * 1977-04-25 1977-10-25 Rit Rech Ind Therapeut Nouveau vaccin vivant ameliore contre le pseudopeste aviaire et son procede de preparation
DE2966914D1 (en) * 1978-09-14 1984-05-24 Gist Brocades Nv Combined vaccine active against newcastle disease and egg production drop caused by adeno-like viruses, process for preparing it, adeno-like and newcastle disease virus strains
SU826584A1 (ru) * 1979-10-29 1982-11-07 Всесоюзный государственный научно-контрольный институт ветеринарных препаратов Вакцина против ньюкаслской болезни птиц,способ ее изготовлени и способ профилактики ньюкаслской болезни птиц

Also Published As

Publication number Publication date
US5149530A (en) 1992-09-22
IE892284L (en) 1990-01-18
DE68918649D1 (de) 1994-11-10
HU204439B (en) 1992-01-28
EP0351908A1 (de) 1990-01-24
ES2060740T3 (es) 1994-12-01
IE65736B1 (en) 1995-11-15
JP2655726B2 (ja) 1997-09-24
EP0351908B1 (de) 1994-10-05
JPH0269422A (ja) 1990-03-08
HUT52703A (en) 1990-08-28
DK347189A (da) 1990-01-19
DK347189D0 (da) 1989-07-13
DK175318B1 (da) 2004-08-16
ATE112490T1 (de) 1994-10-15

Similar Documents

Publication Publication Date Title
ES2176232T3 (es) Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter.
ES2095355T3 (es) Material transparente para usos dentales.
DE3486293T4 (de) Impfstoff-Zubereitung.
IL78913A (en) Synthetic vaccines for foot and mouth disease,their preparation and use
NO904342L (no) Fiskevaksine omfattende en virulent, inntrengende bakterie
GB2202327B (en) Influenza vaccine
ATE112490T1 (de) Lebende newcastle-krankheit-virus-vakzine.
FR2348704A1 (fr) Procede de preparation d'un vaccin contre le virus de la rhinopneumonie equine et vaccin ainsi obtenu
ATE102650T1 (de) Mutanten des infektioesen bovinen rhinotracheitisvirus, vakzine die sie enthalten, verfahren zu ihrer herstellung und ihrer verwendung.
DE3764235D1 (de) Ifosfamid-lyophilisat und verfahren zu dessen herstellung.
CA2273074A1 (en) In ovo vaccination against newcastle disease
CA2015828A1 (en) Canine corona virus vaccine
FR2580176B1 (fr) Vaccin antirabique avirulent
DE3681229D1 (de) Impfstoffe fuer einen tag alte huehner gegen die infektioese bronchitis.
ES2058570T3 (es) Procedimiento para la obtencion de una vacuna antirrabica no virulenta.
DE3279264D1 (en) Method of immunizing pigs against aujeszky's disease
ES482549A0 (es) Un metodo para la preparacion de una composicion de virus herpes
IT1276509B1 (it) Vaccino per la profilassiimmunitaria dell'infezione da virus della immunodeficienza felina del gatto domestico.
ATE84722T1 (de) Tollwut-lebendimpfstoff.
IT8622348A0 (it) 2-bromo,1',2',-dicloro-perfluoro dietil-etere e procedimento per lasua preparazione.
ES550006A0 (es) Procedimiento de obtencion de una vacuna para prevenir la hepatitis b.
DE216901T1 (de) Immunogenes antigen-traeger-proteinkonjugat zur verwendung in impfstoffen gegen malaria.
UA5663A1 (uk) Спосіб підвищення біологічної активності вірусів грипу

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: DIMMINACO AG, ADLISWIL, CH